Published in Pharma Law Weekly, November 2nd, 2004
More than 90% of senior executives believe that product lifecycle management is important for their future prosperity, with 60% saying its importance will increase significantly in their organizations over the next 5 years.
This increased focus stems from concern over the failure of research and development activities to maintain a steady stream of new blockbuster drugs. This leaves...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.